Rodrigues-Amorim, Daniela http://orcid.org/0000-0002-0469-0534
Rivera-Baltanás, Tania http://orcid.org/0000-0002-3723-6039
Fernández-Palleiro, Patricia
Iglesias-Martínez-Almeida, Marta http://orcid.org/0000-0002-9131-8617
Freiría-Martínez, Luis http://orcid.org/0000-0002-9177-0988
Jarmardo-Rodriguez, Cynthia
del Carmen Vallejo-Curto, María
Álvarez-Ariza, María
López-García, Marta
de las Heras, Elena
García-Caballero, Alejandro http://orcid.org/0000-0001-5714-8266
Olivares, José Manuel http://orcid.org/0000-0003-0784-9720
Spuch, Carlos http://orcid.org/0000-0002-9161-0124
Funding for this research was provided by:
Fundação para a Ciência e a Tecnologia (SFRH/BD/135623/2018)
Instituto de Salud Carlos III (P16/00405)
Ministerio de Sanidad, Servicios Sociales e Igualdad (2017I054)
Axencia Galega de Innovación (IN607C-2017/02, IN607B 2018/17, IN606A-2019/025)
Article History
Received: 14 December 2020
Accepted: 1 March 2021
First Online: 12 March 2021
Declarations
:
: Jose Manuel Olivares declared paid positions, honoraria and advisory boards by Angelini, AstraZeneca, Bristol-Myers, Casen Ricordati, GSK, Janssen, Lilly, Lundbeck, Novartis, Otsuka, Pfizer, Sanofi. The rest of the authors declare no conflict of interest.
: Ethical approval for this study was obtained from Ethics Committee (<i>Galician Network of Research Ethics Committees</i> and <i>Scientific and Ethics Committee of the IISGS Biobank).</i>
: Informed consent was obtained from all individual participants included in the study.
: Not applicable.